The Syndromic Standard: Explore the Clinical Impact of mPCR GI Panels for Gastroenteritis
-
Speaker: Jordan E. Axelrad, MD, MPH, FACG, Co-Director of the Inflammatory Bowel Disease Center at NYU, Langone Health Associate Professor of Medicine in the Division of Gastroenterology, Department of Medicine, NYU Grossman School of Medicine
-
Key Topics: Gastroenteritis, GI diagnostics, Syndromic Testing, GI Pathogens, Patient Impact, Testing Utilization
- Duration: 60 minutes
Watch now!
Fill out the form below to view.
What's covered in this webinar?
Join us for an insightful discussion on the evolving landscape of gastrointestinal molecular diagnostics. Learn how the BIOFIRE® Gastrointestinal (GI) molecular portfolio is revolutionizing diagnostics, enabling accurate identification of bacterial, viral, and parasitic pathogens with the introduction of the BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid. Attendees will also gain valuable insight on the burden of gastroenteritis compiled by traditional stool testing, the clinical utility of the bioMérieux GI testing portfolio, in addition to testing implementation, utilization, and result interpretation. Discover how this solution supports clinicians in reducing diagnostic uncertainty, improving time-to-treatment, and advancing patient outcomes.
Learning objectives:
- Examine the burden of gastroenteritis and impact of traditional gastrointestinal pathogen testing on current patient care.
- Explore the expanded bioMérieux BIOFIRE GI molecular diagnostics portfolio and the clinical impact of rapid, syndromic GI diagnostics on patient outcomes.
- Discuss implementation, utilization, and result interpretation from the BIOFIRE GI Portfolio.
